Combined DNA vaccines formulated in DDA enhance protective immunity against tuberculosis.
暂无分享,去创建一个
[1] N. Reiner,et al. The 19-kDa Mycobacterium tuberculosis Protein Induces Macrophage Apoptosis Through Toll-Like Receptor-21 , 2003, The Journal of Immunology.
[2] D. Purdie,et al. Prime Boost Vaccination Strategies: CD8 T Cell Numbers, Protection, and Th1 Bias1 , 2003, The Journal of Immunology.
[3] R. G. Hewinson,et al. Evaluation of adjuvants for protein vaccines against tuberculosis in guinea pigs. , 2003, Vaccine.
[4] P. Krammer,et al. IFN-γ Represses IL-4 Expression via IRF-1 and IRF-2 , 2002 .
[5] B. Haagmans,et al. Protective Antiviral Immune Responses to Pseudorabies Virus Induced by DNA Vaccination Using Dimethyldioctadecylammonium Bromide as an Adjuvant , 2002, Journal of Virology.
[6] K. Huygen,et al. Improved Tuberculosis DNA Vaccines by Formulation in Cationic Lipids , 2002, Infection and Immunity.
[7] R. G. Hewinson,et al. Vaccination of Guinea Pigs with DNA Encoding the Mycobacterial Antigen MPB83 Influences Pulmonary Pathology but Not Hematogenous Spread following Aerogenic Infection with Mycobacterium bovis , 2002, Infection and Immunity.
[8] H. McShane,et al. Protective Immunity against Mycobacterium tuberculosis Induced by Dendritic Cells Pulsed with both CD8+- and CD4+-T-Cell Epitopes from Antigen 85A , 2002, Infection and Immunity.
[9] G. Delogu,et al. DNA Vaccine Combinations Expressing Either Tissue Plasminogen Activator Signal Sequence Fusion Proteins or Ubiquitin-Conjugated Antigens Induce Sustained Protective Immunity in a Mouse Model of Pulmonary Tuberculosis , 2002, Infection and Immunity.
[10] M. Ferrari,et al. Vaxfectin enhances antigen specific antibody titers and maintains Th1 type immune responses to plasmid DNA immunization. , 2001, Vaccine.
[11] P. Andersen,et al. Protection of Mice with a Tuberculosis Subunit Vaccine Based on a Fusion Protein of Antigen 85B and ESAT-6 , 2001, Infection and Immunity.
[12] Olivier Denis,et al. Improved Immunogenicity and Protective Efficacy of a Tuberculosis DNA Vaccine Encoding Ag85 by Protein Boosting , 2001, Infection and Immunity.
[13] E. Agger,et al. Tuberculosis subunit vaccine development: on the role of interferon-gamma. , 2001, Vaccine.
[14] M. Ferrari,et al. Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens. , 2001, Vaccine.
[15] H. McShane,et al. Enhanced Immunogenicity of CD4+ T-Cell Responses and Protective Efficacy of a DNA-Modified Vaccinia Virus Ankara Prime-Boost Vaccination Regimen for Murine Tuberculosis , 2001, Infection and Immunity.
[16] M. Horwitz,et al. Recombinant bacillus calmette-guerin (BCG) vaccines expressing the Mycobacterium tuberculosis 30-kDa major secretory protein induce greater protective immunity against tuberculosis than conventional BCG vaccines in a highly susceptible animal model. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. G. Hewinson,et al. Comparison of the protective efficacy of bacille calmette-Guérin vaccination against aerosol challenge with Mycobacterium tuberculosis and Mycobacterium bovis. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] S. Morris,et al. The immunogenicity of single and combination DNA vaccines against tuberculosis. , 2000, Vaccine.
[19] T. Klabunde,et al. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines , 2000, Nature Structural Biology.
[20] S. Gurunathan,et al. DNA vaccines: immunology, application, and optimization*. , 2000, Annual review of immunology.
[21] G. Delogu,et al. Immunogenicity of DNA Vaccines Expressing Tuberculosis Proteins Fused to Tissue Plasminogen Activator Signal Sequences , 1999, Infection and Immunity.
[22] H. Vordermeier,et al. Development of Diagnostic Reagents To Differentiate between Mycobacterium bovis BCG Vaccination and M. bovis Infection in Cattle , 1999, Clinical Diagnostic Laboratory Immunology.
[23] I. Orme,et al. Immunogenicity and protective efficacy of DNA vaccines encoding secreted and non-secreted forms of Mycobacterium tuberculosis Ag85A. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[24] W. Britton,et al. Differential Protective Efficacy of DNA Vaccines Expressing Secreted Proteins of Mycobacterium tuberculosis , 1999, Infection and Immunity.
[25] C. Chintu,et al. An African perspective on the threat of tuberculosis and HIV/AIDS—can despair be turned to hope? , 1999, The Lancet.
[26] Alan D. Roberts,et al. Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis , 1998, Infection and Immunity.
[27] R. Appelberg,et al. Adjuvant modulation of immune responses to tuberculosis subunit vaccines , 1997, Infection and immunity.
[28] R. G. Hewinson,et al. Heterogenous Expression of the Related MBP70 and MPB83 Proteins Distinguish Various Substrains of Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv , 1996, Scandinavian journal of immunology.
[29] J. Pollock,et al. Immunoblot analysis of humoral immune responses to Mycobacterium bovis in experimentally infected cattle: early recognition of a 26-kilodalton antigen. , 1994, Clinical and diagnostic laboratory immunology.
[30] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.